MircoRNAs predict and modulate responses to chemotherapy in leukemic patients

Area of Science:

• Oncology
• Molecular Biology
• Genetics

Background:

• Leukemia comprises various blood and bone marrow cancers with limited effective treatments and frequent relapses.
• MicroRNAs (miRNAs) are small non-coding RNAs regulating gene expression, epigenetics, and cellular functions like apoptosis and angiogenesis.
• Genetic abnormalities in white blood cell maturation drive uncontrolled proliferation and reduced cell death in leukemia.

Purpose of the Study:

• To review current research on microRNAs in leukemia.
• To examine the role of miRNAs in cancer advancement and spread.
• To explore the potential of miRNAs as diagnostic markers and therapeutic targets for leukemia.

Main Methods:

• Literature review of studies on microRNAs and leukemia.
• Analysis of miRNA involvement in oncogenesis, tumor suppression, and cellular processes.
• Integration of miRNA functions with leukemia patient care strategies.

Main Results:

• MicroRNAs significantly regulate key cancer-related processes including angiogenesis, migration, apoptosis, and gene expression.
• Evidence suggests miRNAs influence leukemia's responsiveness to chemotherapy.
• MiRNAs are implicated in activating oncogenes and deactivating tumor suppressor genes in leukemia.

Conclusions:

• MicroRNAs represent promising therapeutic targets and diagnostic indicators for leukemia.
• Understanding miRNA functions offers new insights into leukemia detection and management.
• MiRNAs play a crucial role in leukemia development, progression, and treatment response.